# Phase I/II Trial of Endometrial Regenerative Cells (ERC) in Patients With Critical Limb Ischemia

> **NCT01558908** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Medistem Inc.** · enrollment: 15 (estimated)

## Conditions studied

- Peripheral Vascular Diseases

## Interventions

- **BIOLOGICAL:** Administration of ERC

## Key facts

- **NCT ID:** NCT01558908
- **Lead sponsor:** Medistem Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2013-05
- **Final completion:** 2013-07
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2012-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01558908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01558908, "Phase I/II Trial of Endometrial Regenerative Cells (ERC) in Patients With Critical Limb Ischemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01558908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*